So it is conceivable that high expression level of ACE2 is an independent risk factor leading to a poorer prognosis in breast cancer patients, and hazard ratio demonstrated here indicates ACE2 expression is not a protective factor in breast cancer. Here, ACE2 is linked to breast carcinoma.